Company information was changed. Attributes: address from 50 Raffles Place #32-01 Singapore Land Tower Singapore 048623 to 50 Raffles Place #32-01 Singapore Land Tower One Singapore 048623
Director Bristol James Arthur 🟢 acquired 13.4K shares (2 derivative) of Ernexa Therapeutics Inc. (ERNA) at $4.57 Transaction Date: Aug 31, 2026 | Filing ID: 041137
Director Cicala Peter 🟢 acquired 11.0K shares (2 derivative) of Ernexa Therapeutics Inc. (ERNA) at $4.57 Transaction Date: Aug 31, 2026 | Filing ID: 041135
Director Polinsky David 🟢 acquired 5.1K shares (1 derivative) of Ernexa Therapeutics Inc. (ERNA) at $4.57 Transaction Date: Aug 31, 2026 | Filing ID: 041133
Director Wexler William A. 🟢 acquired 5.9K shares (1 derivative) of Ernexa Therapeutics Inc. (ERNA) at $4.57 Transaction Date: Aug 31, 2026 | Filing ID: 041132
Director Ratner Elena 🟢 acquired 5.9K shares (1 derivative) of Ernexa Therapeutics Inc. (ERNA) at $4.57 Transaction Date: Aug 31, 2026 | Filing ID: 041131
Director Luther Sanjeev 🟢 acquired 118.8K shares (1 derivative) of Ernexa Therapeutics Inc. (ERNA) at $4.57 Transaction Date: Aug 31, 2026 | Filing ID: 041130
Director Carter Denise P. 🟢 acquired 30.7K shares (1 derivative) of Quoin Pharmaceuticals, Ltd. (QNRX) at $6.10 Transaction Date: Aug 31, 2026 | Filing ID: 104405